New decision memos on the management of scientific departments

At its session on April 28, 2017, the Board of Directors extended the term of:

 

• Chiara Zurzulo, Director of the Cell Biology and Infection Department, for a period of two years from July 1, 2016

More information in decision memo 660

 

• Michael Nilges, Director of the Structural Biology and Chemistry Department, for a period of two years from July 1, 2016

More information in decision memo 661

 

• Didier Mazel, Director of the Genomes and Genetics Department, for a period of two years from July 1, 2016

More information in decision memo 662

 

• Gérard Eberl, Director of the Immunology Department, for a period of two years from July 1, 2016

More information in decision memo 663

 

• Marie-Lise Gougeon, Director of the Infection and Epidemiology Department, for a period of two years from July 1, 2016

More information in decision memo664

 

• Hilde De Reuse, Director of the Microbiology Department, for a period of two years from July 1, 2016

More information in decision memo 665

 

• Pierre-Marie Lledo, Director of the Neuroscience Department, for a period of two years from July 1, 2016

More information in decision memo 666

 

• Monique Lafon, Director of the Virology Department, for a period of two years from July 1, 2016

More information in decision memo 668

 

• Christophe d’Enfert, Director of the Mycology Department, for a period of two years from November 1, 2016

More information in decision memo 675

 

 

At its session on April 28, 2017, the Board of Directors appointed:

 

• François Schweisguth, Director of the Developmental and Stem Cell Biology Department, for a renewable two-year term from July 1, 2016

More information in decision memo 658

 

• Gerald Spaeth, Director of the Parasites and Insect Vectors Department, for a renewable two-year term from July 1, 2016

More information in decision memo 667